Spratt and Macmillan rise at Rotech

Sunday, August 14, 2005

ORLANDO, Fla. -- Rotech Healthcare has named Greg Spratt as the company's chief clinical officer with responsibilities for all aspects of Rotech's clinical programs, including the operation of Pulmo Dose Pharmacy and Sleep Central for Rotech Healthcare.

Spratt has worked at Rotech for 18 years, most recently as the company's national clinical director. Nick Macmillan, another veteran of the industry's respiratory niche, will take over Spratt's old job.

"Greg's insight to the importance and benefit of quality patient care has helped Rotech to achieve many of its growth objectives," Rotech CEO Phillip L. Carter said a press release, announcing the news.

Over the last 15 years, Macmillan's positions have included work as a director of respiratory care and new business development, vice president of HME Operations, and corporate compliance officer with two regional HME providers. For the past four years, Macmillan has been with Sunrise Medical - DeVilbiss, where he most recently served as global sleep product Director.

"We feel Nick's outside experiences will complement our executive management team's vision for the future and look forward to his perspectives and contributions," said Carter.